Literature DB >> 1734220

Neuroblastoma with intracranial involvement: an ENSG Study.

P J Shaw1, T Eden.   

Abstract

We report the experience of the European Neuroblastoma Study Group (ENSG) with central nervous system (CNS) involvement of neuroblastoma. Among this series of intensively treated patients, CNS neuroblastoma was diagnosed by computerised tomography (CT) scanning, rather than by autopsy. Cranial disease occurred in 5% of ENSG patients. Of 11 patients with intracranial disease, 4 had disease in the posterior fossa, a site rarely reported previously. Furthermore, 5 cases had CNS metastases at a time when there was no detectable disease elsewhere, rather than as part of extensive relapse. The pattern of disease we observed, at least for those with parenchymal disease, is in keeping with arterial spread. Although CT scanning is the optimal modality for identifying CNS disease, 2 cases had normal head CT scans prior to the onset of CNS disease. As most patients had symptoms of raised intracranial pressure (RICP) at the time the CNS disease was diagnosed, there does not seem to be any indication for routine CT scanning of the head at diagnosis, but this should be performed as soon as any symptoms or signs appear. With patients living longer with their disease, vigilance must be maintained during follow-up.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734220     DOI: 10.1002/mpo.2950200211

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  7 in total

1.  Neo-adjuvant chemotherapy followed by surgery for extensive calvarial metastases of a neuroblastoma.

Authors:  Sang-Deok Kim; Tae-Young Jung; Shin Jung; Hee-Jo Baek
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

Review 2.  Brain metastasis in pediatric extracranial solid tumors: survey and literature review.

Authors:  Rejin Kebudi; Inci Ayan; Omer Görgün; Fulya Yaman Ağaoğlu; Sema Vural; Emin Darendeliler
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid.

Authors:  Ping He; Kim Kramer; Peter Smith-Jones; Pat Zanzonico; John Humm; Steven M Larson; Nai-Kong V Cheung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10-09       Impact factor: 9.236

4.  Neurological complications of neuroblastic tumors: experience of a single center.

Authors:  G Burca Aydin; M Tezer Kutluk; Munevver Buyukpamukcu; Canan Akyuz; Bilgehan Yalcin; Ali Varan
Journal:  Childs Nerv Syst       Date:  2009-08-28       Impact factor: 1.475

5.  Unusual CNS presentation of neuroblastoma.

Authors:  J C Egelhoff; C Zalles
Journal:  Pediatr Radiol       Date:  1996

6.  Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma.

Authors:  M R Aronson; W R Smoker; G M Oetting
Journal:  Pediatr Radiol       Date:  1995

7.  A Novel Anticancer Agent, 8-Methoxypyrimido[4',5':4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and -Independent Apoptotic Pathways.

Authors:  Upasana Sahu; Himakshi Sidhar; Pankaj S Ghate; Gopal M Advirao; Sathees C Raghavan; Ranjit K Giri
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.